Pfizer Inc
PFE- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000078003
In the last 90 days, Pfizer Inc insiders filed 3 open-market purchases and 1 sale; 2,843 institutions reported holding it in 13F filings for Q2 2026, worth $91.9B in total; Fairfax Financial is the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Pfizer Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 3,271 | 70 | 3,112 | −89 |
| Shares | 3.91B | 7.83M | 3.93B | +24.7M (+0.6%) |
| Value | $200.2B | $385.1M | $160.4B | −$39.5B (−19.8%) |
70 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (140)
Institutions that held Pfizer Inc at the end of Q1 2023 but not at the end of Q4 2022.
Showing the largest 100 of 140 by value.
Sold out (229)
Institutions that held Pfizer Inc at the end of Q4 2022 and filed for Q1 2023 without it.
Showing the largest 100 of 229 by value.
Not filed for Q1 2023 yet (70)
Institutions that held Pfizer Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.